According to Citi this month, in respect to HLS, 'Radiology performed well. Imaging revenue increased by 9% and EBIT increased by 12%.' Whilst revenue seems OK for CAJ, it is the EBIT or EBITDA which is the problem. AH must assert his authority over the now reconstituted radiology group!
CAJ, page-140
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 36.5¢ | $96.86K | 262.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 121727 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 205507 | 43 |
View Market Depth
| Last trade - 15.11pm 26/11/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |
